Home › NDC Lookup › RxCUI directory › RxCUI 2739831

Atomoxetine 4 MG/ML Oral Solution — RxCUI 2739831

RxNorm drug concept · Semantic clinical drug
RxCUI 2739831 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2739831
Official nameAtomoxetine 4 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asatomoxetine 4 MG (as atomoxetine hydrochloride 4.57 MG) per ML Oral Solution
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Atomoxetine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats ADHD in adults and in children 6 and older. It's not a stimulant, and it works best as part of a full plan that can include behavioral, educational and social support.
  • Take it by mouth once a day in the morning, or split into two doses in the morning and late afternoon or early evening, as your prescriber directs. Food doesn't matter. Swallow cap...
  • In children, the most common are nausea, vomiting, tiredness, stomach pain, sleepiness and lower appetite. Adults more often notice dry mouth, constipation, dizziness, lower appeti...
  • Atomoxetine carries a boxed warning for suicidal thoughts in children and teens, mostly early in treatment. Watch daily for agitation, irritability, anxiety, aggression, panic or u...
📖 Read our full Atomoxetine guide →

🕸️ Concept Web — How Atomoxetine 4 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Atomoxetine 4 MG/ML Oral Solution RxCUI 2739831

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Atomoxetine 38400
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Atoncy 2739832
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Atomoxetine Oral Solution 2739830
    • Atomoxetine Oral Liquid Product 2739829
    • Atomoxetine Oral Product 1158282
    • Atomoxetine Oral Solution [Atoncy] 2739836
    • Atoncy Oral Liquid Product 2739835
    • Atoncy Oral Product 2739834
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Atomoxetine 4 MG/ML SCDC · 2739828
  • Atomoxetine Oral Solution SCDF · 2739830
  • Atomoxetine Oral Liquid Product SCDG · 2739829
  • Atomoxetine Oral Product SCDG · 1158282

Brand-Name Concepts

  • Atomoxetine 4 MG/ML Oral Solution [Atoncy] SBD · 2739837
  • Atomoxetine 4 MG/ML [Atoncy] SBDC · 2739833
  • Atomoxetine Oral Solution [Atoncy] SBDF · 2739836
  • Atoncy Oral Liquid Product SBDG · 2739835
  • Atoncy Oral Product SBDG · 2739834
  • Atoncy BN · 2739832

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2739831 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
30698-0456-02 1 BOTTLE, GLASS in 1 CARTON (30698-456-02) / 100 mL in 1 BO... ATONCY Validus Pharmaceuticals LLC 2026-03-20
72888-0456-01 1 BOTTLE, GLASS in 1 CARTON (72888-456-01) / 100 mL in 1 BO... Atomoxetine hydrochloride Advagen Pharma Ltd. 2026-03-20
Observed labelers: Advagen Pharma Ltd. (1) · Validus Pharmaceuticals LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.